Literature DB >> 23263842

Rotenone-dependent changes of anterograde motor protein expression and mitochondrial mobility in brain areas related to neurodegenerative diseases.

Thaiany Q Melo1, Aline M D'unhao, Stephanie A Martins, Karen L G Farizatto, Rodrigo S Chaves, Merari F R Ferrari.   

Abstract

The presence of protein aggregates is common in neurodegenerative disorders; however, the real cause and effect of these aggregates during neurodegeneration is still a matter of investigation. We hypothesize that impairment of intracellular traffic may appear in the absence of protein inclusions and might trigger protein aggregation. In the present study, we aimed to evaluate mitochondria mobility as well as protein and messenger RNA expression of KIF1B and KIF5 that are molecular motors for neuronal anterograde traffic, in hippocampus, substantia nigra, and locus coeruleus of 10-month-old Lewis rats and cultured cells, from these same areas, following exposure to low doses of rotenone that do not lead to protein inclusions. The present study showed alteration in KIF1B and KIF5 expression, as well as in mitochondria mobility prior to protein aggregation involved in neurodegenerative disorders. These findings suggest that change in intracellular trafficking might be critical and one of the primary events for impairment of cell physiology during neurodegeneration associated with protein inclusions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23263842     DOI: 10.1007/s10571-012-9898-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  43 in total

1.  Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I.

Authors:  A Kamal; G B Stokin; Z Yang; C H Xia; L S Goldstein
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP.

Authors:  A Kamal; A Almenar-Queralt; J F LeBlanc; E A Roberts; L S Goldstein
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

Review 3.  Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders.

Authors:  Lucian Soane; Sibel Kahraman; Tibor Kristian; Gary Fiskum
Journal:  J Neurosci Res       Date:  2007-11-15       Impact factor: 4.164

4.  Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.

Authors:  Nicholas M Kanaan; Gerardo A Morfini; Nichole E LaPointe; Gustavo F Pigino; Kristina R Patterson; Yuyu Song; Athena Andreadis; Yifan Fu; Scott T Brady; Lester I Binder
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

Review 5.  Opinion: What is the role of protein aggregation in neurodegeneration?

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

6.  Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.

Authors:  Beth Arnold; Steven J Cassady; Victor S VanLaar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2010-09-17       Impact factor: 5.996

7.  Differential degeneration of the locus coeruleus in dementia subtypes.

Authors:  H Brunnström; N Friberg; E Lindberg; E Englund
Journal:  Clin Neuropathol       Date:  2011 May-Jun       Impact factor: 1.368

8.  Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.

Authors:  T Arendt; M K Brückner; V Bigl; L Marcova
Journal:  J Comp Neurol       Date:  1995-01-09       Impact factor: 3.215

9.  Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin.

Authors:  Madhuchhanda Mandal; Jing Wei; Ping Zhong; Jia Cheng; Lara J Duffney; Wenhua Liu; Eunice Y Yuen; Alison E Twelvetrees; Shihua Li; Xiao-Jiang Li; Josef T Kittler; Zhen Yan
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

10.  Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A.

Authors:  Chun-Hong Xia; Elizabeth A Roberts; Lu-Shiun Her; Xinran Liu; David S Williams; Don W Cleveland; Lawrence S B Goldstein
Journal:  J Cell Biol       Date:  2003-04-07       Impact factor: 10.539

View more
  7 in total

1.  Circ_0049472 regulates the damage of Aβ-induced SK-N-SH and CHP-212 cells by mediating the miR-107/KIF1B axis.

Authors:  Chaosheng Zeng; Huaijie Xing; Min Chen; Lin Chen; Pengxiang Li; Xiaowen Wu; Li Li
Journal:  Exp Brain Res       Date:  2022-07-26       Impact factor: 2.064

2.  A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo.

Authors:  Ana Lopez; Alena Gorb; Nuno Palha; Angeleen Fleming; David C Rubinsztein
Journal:  Genes (Basel)       Date:  2022-05-12       Impact factor: 4.141

Review 3.  Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum.

Authors:  Thaiany Quevedo Melo; Sjef J C V M Copray; Merari F R Ferrari
Journal:  Neurochem Res       Date:  2018-10-28       Impact factor: 3.996

4.  Role of Dynein Axonemal Heavy Chain 6 Gene Expression as a Possible Biomarker for Huntington's Disease: a Translational Study.

Authors:  Lorena B Areal; Lorraine P Pereira; Fabiola M Ribeiro; Isabella G Olmo; Marcelo R Muniz; Maria do Carmo Rodrigues; Patrik F Costa; Cristina Martins-Silva; Stephen S G Ferguson; Daniela A M Guimarães; Rita G W Pires
Journal:  J Mol Neurosci       Date:  2017-10-10       Impact factor: 3.444

5.  Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.

Authors:  T Q Melo; K C van Zomeren; M F R Ferrari; H W G M Boddeke; J C V M Copray
Journal:  Exp Brain Res       Date:  2016-11-19       Impact factor: 1.972

6.  BDNF trafficking and signaling impairment during early neurodegeneration is prevented by moderate physical activity.

Authors:  Michael F Almeida; Rodrigo S Chaves; Carolliny M Silva; Juliana C S Chaves; Karla P Melo; Merari F R Ferrari
Journal:  IBRO Rep       Date:  2016-08-30

7.  DYNLT1 gene expression is downregulated in whole blood of patients at different Huntington's disease stages.

Authors:  S M Rosseto; T A Alarcon; D M C Rocha; F M Ribeiro; S S G Ferguson; C Martins-Silva; M R Muniz; P F Costa; D A Guimarães; Rita G W Pires
Journal:  Neurol Sci       Date:  2020-09-29       Impact factor: 3.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.